Hanmi Pharm and GC Biopharma license Fabry disease new drug for up to $475M in technology exports
Predicted impact: Medium
Up to $475M licensing deal, repeating the earlier Fabry drug export news.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.